Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11103773.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inherited mutations of the RET proto-oncogene are tumorigenic in patients with multiple endocrine neoplasia type 2 (MEN 2). However, it is not understood why only few of the affected cells in the target organs develop into tumors. Genetic analysis of nine pheochromocytomas from five unrelated patients with MEN 2 showed either duplication of the mutant RET allele in trisomy 10 or loss of the wild-type RET allele. Our results suggest a "second hit" causing a dominant effect of the mutant RET allele, through either duplication of the mutant allele or loss of the wild-type allele, as a possible mechanism for pheochromocytoma tumorigenesis in patients with MEN 2.
Medical subject headings
- Adrenal Gland Neoplasms
- Chromosomes, Human, Pair 10
- Drosophila Proteins
- Loss of Heterozygosity
- Multiple Endocrine Neoplasia Type 2a
- Pheochromocytoma
- Proto-Oncogene Proteins
- Receptor Protein-Tyrosine Kinases
- Trisomy